Upgrade to SI Premium - Free Trial

Tandem Diabetes Care (TNDM) PT Lowered to $20 at Mizuho

July 15, 2026 6:40 AM
Mizuho analyst Anthony Petrone lowered the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $20.00 (from $24.00) while maintaining a Neutral rating.

Categories

Analyst PT Change